Bladder cancer with muscle invasion;Muskelinvasives harnblasenkarzinom

Deutsches Arzteblatt

Volumn 104, Issue 13, 2007, Pages 868-872

  Frohneberg, Detlef ^a  

^a STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

Author keywords

Adjuvant; Bladder cancer; Chemotherapy; Combined radiochemotherapy; Cystectomy; Neoadjuvant

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURGERY; CYSTECTOMY; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MUSCLE METASTASIS; REVIEW; URETHRA SURGERY;

EID: 34247468933     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Wunderlich H, Wolf M, Reichelt O et al.: Radical cystectomy with ultrasound-guided partial prostatectomy for bladder cancer. Urology 2006; 68: 554-9.
2. Gschwend JE, Dahm P, Fair WR: Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol 2002; 41: 440-8.
3. Varol C, Thalmann GN, Burkhard FC, Studer UE: Treatment of urethral recurrence following radical cystectomy and ileal bladder substitution. J Urol 2004; 172: 937-42.
4. Hassan JM, Cookson MS, Smith JA Jr., Chang SS: Urethral recurrence in patients following orthotopic urinary diversion. J Urol 2004; 172: 1338-41.
5. Simon J, Gschwend JE, Volkmer BG: Lokalrezidiv nach radikaler Zystektomie bei Harnblasenkarzinom. Der Urologe 2005; 44: 375-81.
6. Poulson AL, Horn T, Steven K: Radical cystektomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 1998; 160: 2015-19.
7. Leissner J, Hohenfellner R, Thüroff JW, Wolf HK: Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis BJU Int 2000; 85: 817-23.
8. Herr H: Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology 2003; 61: 105-08.
9. Rodel C, Weiss C, Sauer R: Organ preservation by combined modality treatment in bladder cancer: the European perspective. Semin Radiat Oncol 2005; 15: 28-35.
10. Coppin CM, Gospodarowicz MK, James K et al.: Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1996; 14: 2901-7.
11. Rödel C, Grabenbauer GG, Kuhn R et al.: Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 2002; 20: 3061-71.
12. Nieuwenhuijzen JA, Horenblas S, Meinhardt W et al.: Salvage cystectomy after failure of interstitial radiotherapy and external beam radiotherapy in bladder cancer. BJU Int 2004; 94: 793-97.
13. Housset M, Maulard C, Chretien Y et al.: Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol 1993; 11: 2150-7.
14. Housset M, Dufour B, Maulard-Durdux C, Chretien Y, Mejean A: Concomitant fluorouracil (5-FU)-cisplatin (CDDP) and bifractionated split course radiation therapy (BSCRT) for invasive bladder cancer. Proc Am Soc Clin Oncol 1997;16: 319a (abstract).
15. Shipley WU, Zietman AL, Kaufman DS, Coen JJ, Sandler HM: Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates - the Massachusetts General Hospital and Radiation Therapy Oncology Group experiences. Semin Radiat Oncol 2005; 15: 36-41.
16. Stein JP, Lieskovsky G, Cote R et al.: Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 2001; 19: 666-75.
17. Schoborg TW, Sapolsky JL, Lewis CW Jr.: Carcinoma of the bladder treated by segmental resection. J Urol 1979; 122: 473-5.
18. Sweeney P, Kursh ED, Resnick MI: Partial cystectomy. Urol Clin North Am 1992; 19: 701-11.
19. Skinner DG, Daniels JR, Russell CA et al.: The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 1991; 145: 459-64.
20. Stockle M, Meyenburg W, Wellek S, Voges G, Gertenbach U, Thuroff JW, Huber C, Hohenfellner R: Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J Urol 1992; 148: 302-6.
21. Stöckle M, Wellek S, Meyenburg W et al.: Radical cystectomy with or without adjuvant polychemotherapy for non-organ-confined transitional cell carcinoma of the urinary bladder: prognostic impact on lymph node involvement. Urology 1996; 48: 868-75.
22. Freiha F, Reese J, Torti FM: A randomized trial of radical cystectomy versus radical cystecomty plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 1996; 155: 495-99.
23. Lehmann J, Retz M, Wiemers Ch et al.: Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB05/95). J Clin Oncol 2005; 23: 4963-74.
24. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration: Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol 2005; 48: 189-99.
25. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration: Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 2005; 48: 202-5.